Výsledky vyhledávání - "Johanna M M van Oers"

Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber

Autor: Johanna M M van Oers, Jaap Goudsmit, Stefan Kostense, Caroline E. van der Minne, Menzo J. E. Havenga, Elisabeth H. Slager, Marieke Griffioen, Susanne Osanto

Publikováno v: Cancer gene therapy, 11(3), 227-236. Nature Publishing Group

Delivery of the full-length tumor antigen might be more successful in immunotherapy than single peptides and has the advantage that patients no longer need to be selected for their HLA type. In this study, we tested the in vitro induction of CAMEL/NY

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a276e5f3d078588be3be000aafb6505
https://doi.org/10.1038/sj.cgt.7700674

Zobrazit plný text záznamu

[Correlation of FGFR3 mutations and chromosomal alterations in bladder cancer]

Autor: Kerstin, Junker, Johanna M M, van Oers, Ellen C, Zwarthoff, Ines, Kania, Joerg, Schubert, Arndt, Hartmann

Publikováno v: Verhandlungen der Deutschen Gesellschaft fur Pathologie. 90

It has been suggested that mutation of FGFR3 is associated with non-invasive tumors of low malignant potential and low risk of recurrence and progression. The aim of this study was to analyze the distribution of FGFR3 mutations in bladder tumors of d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::039dede32297e8411f8881700001c5ca
https://pubmed.ncbi.nlm.nih.gov/17867592

Zobrazit plný text záznamu

[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]

Autor: Johannes, Giedl, Peter J, Wild, Robert, Stoehr, Kerstin, Junker, Stefan, Boehm, Johanna M M, van Oers, Ellen C, Zwarthoff, Hagen, Blaszyk, Samson W, Fine, Peter A, Humphrey, Louis P, Dehner, Mahul B, Amin, Jonathan I, Epstein, Arndt, Hartmann

Publikováno v: Verhandlungen der Deutschen Gesellschaft fur Pathologie. 90

Urothelial neoplasms in patients 19 years or younger are rare, with conflicting data regarding clinical outcome and no molecular data available.Urothelial tumors of 14 patients 4 to 19 years old were identified, reclassified according to the 2004 WHO

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5bfb8e3f4c38c30dd11cb640e6ae3281
https://pubmed.ncbi.nlm.nih.gov/17867604

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání